Skip to main navigation Skip to search Skip to main content

A Randomized, Open-label, Multicenter, Phase 3 Trial to Assess the Safety of Tobramycin Inhalation Powder Compared to TOBI in Cystic Fibrosis Subjects

Project: Research

Project Details

StatusFinished
Effective start/end date11/14/07 → 08/14/09

Funding

  • Novartis Pharmaceuticals Corporation: $1,500.00